Citations (151)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Danni Wang, Xiaohong Li, Guangyue Gong, Yulong Lu, Ziming Guo, Rui Chen, Huidan Huang, Zhiyu Li & Jinlei Bian. (2023) An updated patent review of glutaminase inhibitors (2019–2022). Expert Opinion on Therapeutic Patents 33:1, pages 17-28.
Read now
Read now
Tianyu Han, Pengcheng Wang, Yanan Wang, Wenze Xun, Jiapeng Lei, Tao Wang, Zhuo Lu, Mingxi Gan, Wei Zhang, Bentong Yu & Jian-Bin Wang. (2022) FAIM regulates autophagy through glutaminolysis in lung adenocarcinoma. Autophagy 18:6, pages 1416-1432.
Read now
Read now
Yanan Wang, Tianyu Han, Mingxi Gan, Meng Guo, Caifeng Xie, Jiangbo Jin, Song Zhang, Pengcheng Wang, Jiaqing Cao & Jian-Bin Wang. (2019) A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancer. Cell Cycle 18:9, pages 1019-1032.
Read now
Read now
Gunnar Boysen, Azemat Jamshidi-Parsian, Mary A. Davis, Eric R. Siegel, Christine M. Simecka, Rajshekhar A. Kore, Ruud P. M. Dings & Robert J. Griffin. (2019) Glutaminase inhibitor CB-839 increases radiation sensitivity of lung tumor cells and human lung tumor xenografts in mice. International Journal of Radiation Biology 95:4, pages 436-442.
Read now
Read now
CanRong Wu, LiXia Chen, Sanshan Jin & Hua Li. (2018) Glutaminase inhibitors: a patent review. Expert Opinion on Therapeutic Patents 28:11, pages 823-835.
Read now
Read now
Roxana S. Redis & George A. Calin. (2016) The interplay between lnRNAs, SNPs, and protein complexes - what does it mean for cancer metabolism?. Molecular & Cellular Oncology 3:4.
Read now
Read now
Articles from other publishers (145)
Chantelle D. Hudson, Alyssa Savadelis, Anil Belur Nagaraj, Peronne Joseph, Stefanie Avril, Analisa DiFeo & Norbert Avril. (2016) Altered glutamine metabolism in platinum resistant ovarian cancer. Oncotarget 7:27, pages 41637-41649.
Crossref
Crossref
Joanna Buczkowska & Monika Szeliga. (2023) Two Faces of Glutaminase GLS2 in Carcinogenesis. Cancers 15:23, pages 5566.
Crossref
Crossref
Zhihong Wang, Taifeng Li, Ruisheng Li, Bo Cao, Shiyuan Wang, Xiaofei Fei, Chunyu Li & Guohui Li. (2023) Sijunzi Tang improves gefitinib resistance by regulating glutamine metabolism. Biomedicine & Pharmacotherapy 167, pages 115438.
Crossref
Crossref
Federica Barreca, Michele Aventaggiato, Laura Vitiello, Luigi Sansone, Matteo Antonio Russo, Antonello Mai, Sergio Valente & Marco Tafani. (2023) SIRT5 Activation and Inorganic Phosphate Binding Reduce Cancer Cell Vitality by Modulating Autophagy/Mitophagy and ROS. Antioxidants 12:8, pages 1635.
Crossref
Crossref
Aggelos T. Margetis. (2022) Metabolic targeting of malignant tumors: a need for systemic approach. Journal of Cancer Research and Clinical Oncology 149:5, pages 2115-2138.
Crossref
Crossref
Prahlad V. Raninga, Yaowu He, Keshava K. Datta, Xue Lu, Uma R. Maheshwari, Pooja Venkat, Chelsea Mayoh, Harsha Gowda, Murugan Kalimutho, John D. Hooper & Kum Kum Khanna. (2023) Combined thioredoxin reductase and glutaminase inhibition exerts synergistic anti-tumor activity in MYC-high high-grade serous ovarian carcinoma. Molecular Therapy 31:3, pages 729-743.
Crossref
Crossref
Changpeng Sun, Hongjun Guan, Jinjin Li & Yinfeng Gu. (2023) circ_0000376 knockdown suppresses non-small cell lung cancer cell tumor properties by the miR-545-3p/PDPK1 pathway. Open Medicine 18:1.
Crossref
Crossref
Sandra Kannampuzha, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Reshma Murali, Arunraj Namachivayam, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Harishkumar Madhyastha & Raja Ganesan. (2023) A Systematic Role of Metabolomics, Metabolic Pathways, and Chemical Metabolism in Lung Cancer. Vaccines 11:2, pages 381.
Crossref
Crossref
Zhongxiao Wang, Felix Yemanyi, Alexandra K Blomfield, Kiran Bora, Shuo Huang, Chi-Hsiu Liu, William R Britton, Steve S Cho, Yohei Tomita, Zhongjie Fu, Jian-xing Ma, Wen-hong Li & Jing Chen. (2022) Amino acid transporter SLC38A5 regulates developmental and pathological retinal angiogenesis. eLife 11.
Crossref
Crossref
Jasmin Sponagel, Jill K. Jones, Cheryl Frankfater, Shanshan Zhang, Olivia Tung, Kevin Cho, Kelsey L. Tinkum, Hannah Gass, Elena Nunez, Douglas R. Spitz, Prakash Chinnaiyan, Jacob Schaefer, Gary J. Patti, Maya S. Graham, Audrey Mauguen, Milan Grkovski, Mark P. Dunphy, Simone Krebs, Jingqin Luo, Joshua B. Rubin & Joseph E. Ippolito. (2022) Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatment. Med 3:11, pages 792-811.e12.
Crossref
Crossref
Jianguo Bai, Ruifeng Tang, Keyu Zhou, Jialei Chang, Hongyue Wang, Qixin Zhang, Jiahui Shi & Chao Sun. (2022) An asparagine metabolism-based classification reveals the metabolic and immune heterogeneity of hepatocellular carcinoma. BMC Medical Genomics 15:1.
Crossref
Crossref
Zhuhui Yuan, Tong Liu, Xiao Huo, Hao Wang, Junjie Wang & Lixiang Xue. (2022) Glutamine Transporter SLC1A5 Regulates Ionizing Radiation-Derived Oxidative Damage and Ferroptosis. Oxidative Medicine and Cellular Longevity 2022, pages 1-19.
Crossref
Crossref
Li-Chun Lin, Hsin-Yi Chang, Tony Eight Lin, Jyh-Ruey Lin, Shih-Min Hsia, Kai-Cheng Hsu & Tsui-Chin Huang. (2022) Structure-based virtual screening discovers novel kidney-type glutaminase inhibitors. Biomedicine & Pharmacotherapy 154, pages 113585.
Crossref
Crossref
Melissa García-Caballero, Liliana Sokol, Anne Cuypers & Peter Carmeliet. (2022) Metabolic Reprogramming in Tumor Endothelial Cells. International Journal of Molecular Sciences 23:19, pages 11052.
Crossref
Crossref
Kevinn Eddy, Mohamad Naser Eddin, Anna Fateeva, Stefano Vito Boccadamo Pompili, Raj Shah, Saurav Doshi & Suzie Chen. (2022) Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression. Cells 11:18, pages 2857.
Crossref
Crossref
Shams Tabrez, Torki A. Zughaibi, Mehboob Hoque, Mohd Suhail, Mohammad Imran Khan & Azhar U. Khan. (2022) Targeting Glutaminase by Natural Compounds: Structure-Based Virtual Screening and Molecular Dynamics Simulation Approach to Suppress Cancer Progression. Molecules 27:15, pages 5042.
Crossref
Crossref
Xin Li, Minghui Liu, Hongyu Liu & Jun Chen. (2022) Tumor metabolic reprogramming in lung cancer progression (Review). Oncology Letters 24:2.
Crossref
Crossref
Joanna Kubik, Ewelina Humeniuk, Grzegorz Adamczuk, Barbara Madej-Czerwonka & Agnieszka Korga-Plewko. (2022) Targeting Energy Metabolism in Cancer Treatment. International Journal of Molecular Sciences 23:10, pages 5572.
Crossref
Crossref
Bin Jiang, Jia Zhang, Guohui Zhao, Mengjue Liu, Jielu Hu, Furong Lin, Jinyang Wang, Wentao Zhao, Huanhuan Ma, Cixiong Zhang, Caiming Wu, Luming Yao, Qingfeng Liu, Xin Chen, Yating Cao, Yi Zheng, Chensong Zhang, Aidong Han, Donghai Lin & Qinxi Li. (2022) Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis. Molecular Cell 82:10, pages 1821-1835.e6.
Crossref
Crossref
Yuwei Feng, Xiaowei Sun, Tiangu Yang, Jingqi Han, Dapeng Zhou, Haitao Ren, Yulong Sheng & Yanhua Wang. (2022) Comprehensive Analysis of Subtypes and Identification of Key lncRNAs Based on Glutamine Metabolism-Related Long Noncoding RNAs. Computational and Mathematical Methods in Medicine 2022, pages 1-16.
Crossref
Crossref
Shagun Sharma, Navneet Agnihotri & Sandeep Kumar. (2022) Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis. Biochemical Pharmacology 198, pages 114943.
Crossref
Crossref
Enyu Tang, Siyang Liu, Zhiming Zhang, Rixin Zhang, Dejing Huang, Tong Gao, Tianze Zhang & Guangquan Xu. (2022) Therapeutic Potential of Glutamine Pathway in Lung Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Maksymilian Baryła, Aleksandra Semeniuk-Wojtaś, Letycja Róg, Leszek Kraj, Maciej Małyszko & Rafał Stec. (2022) Oncometabolites—A Link between Cancer Cells and Tumor Microenvironment. Biology 11:2, pages 270.
Crossref
Crossref
Thuy-Tien T. Nguyen, Sekar Ramachandran, Matthew J. Hill & Richard A. Cerione. (2022) High-resolution structures of mitochondrial glutaminase C tetramers indicate conformational changes upon phosphate binding. Journal of Biological Chemistry 298:2, pages 101564.
Crossref
Crossref
Anna Halama & Karsten Suhre. (2022) Advancing Cancer Treatment by Targeting Glutamine Metabolism—A Roadmap. Cancers 14:3, pages 553.
Crossref
Crossref
Henning Cederkvist, Shrikant S. Kolan, Jonas Aakre Wik, Zeynep Sener & Bjørn Steen Skålhegg. (2021) Identification and characterization of a novel glutaminase inhibitor. FEBS Open Bio 12:1, pages 163-174.
Crossref
Crossref
Wei Yu, XiangYu Yang, Qian Zhang, Li Sun, ShengTao Yuan & YongJie Xin. (2021) Targeting GLS1 to cancer therapy through glutamine metabolism. Clinical and Translational Oncology 23:11, pages 2253-2268.
Crossref
Crossref
Toshifumi Takeuchi, Masaki Hatano, Hideyuki Muramatsu, Yumiko Kubota, Ryuichi Sawa & Masayuki Igarashi. (2021)
Micromonosporamide A with Glutamine-Dependent Cytotoxicity from
Micromonospora
sp. MM609M-173N6: Isolation, Stereochemical Determination, and Synthesis
. Organic Letters 23:20, pages 7981-7985.
Crossref
Crossref
Jossimar Coronel-Hernández, Eloy Andrés Pérez-Yépez, Izamary Delgado-Waldo, Carlos Contreras-Romero, Nadia Jacobo-Herrera, David Cantú-De León & Carlos Pérez-Plasencia. (2021) Aberrant Metabolism as Inductor of Epigenetic Changes in Breast Cancer: Therapeutic Opportunities. Frontiers in Oncology 11.
Crossref
Crossref
James J. Harding, Melinda Telli, Pamela Munster, Martin H. Voss, Jeffrey R. Infante, Angela DeMichele, Mark Dunphy, Mai H. Le, Chris Molineaux, Keith Orford, Frank Parlati, Sam H. Whiting, Mark K. Bennett, Nizar M. Tannir & Funda Meric-Bernstam. (2021) A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors. Clinical Cancer Research 27:18, pages 4994-5003.
Crossref
Crossref
Friederike Steifensand, Julia Gallwas, Gerd Bauerschmitz & Carsten Gründker. (2021) Inhibition of Metabolism as a Therapeutic Option for Tamoxifen-Resistant Breast Cancer Cells. Cells 10:9, pages 2398.
Crossref
Crossref
Thomas N. Seyfried & Christos Chinopoulos. (2021) Can the Mitochondrial Metabolic Theory Explain Better the Origin and Management of Cancer than Can the Somatic Mutation Theory?. Metabolites 11:9, pages 572.
Crossref
Crossref
Yair Romero & Arnoldo Aquino-Gálvez. (2021) Hypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution. International Journal of Molecular Sciences 22:15, pages 8335.
Crossref
Crossref
Molly Endicott, Michael Jones & Jonathon Hull. (2021) Amino acid metabolism as a therapeutic target in cancer: a review. Amino Acids 53:8, pages 1169-1179.
Crossref
Crossref
Chuanfan Zhong, Kaihui Wu, Shuo Wang, Zining Long, Taowei Yang, Weibo Zhong, Xiao Tan, Zixian Wang, Chuanyin Li, Jianming Lu & Xiangming Mao. (2021) Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer. Cell Death & Disease 12:8.
Crossref
Crossref
Suman Mukhopadhyay, Matthew G. Vander Heiden & Frank McCormick. (2021) The metabolic landscape of RAS-driven cancers from biology to therapy. Nature Cancer 2:3, pages 271-283.
Crossref
Crossref
Mofei Huang, Charles R. Myers, Yian Wang & Ming You. (2021) Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents. Cancer Prevention Research 14:3, pages 285-306.
Crossref
Crossref
Laura J Pallett, Sarah Dimeloe, Linda V Sinclair, Adam J Byrne & Anna Schurich. (2021) A glutamine ‘tug-of-war’: targets to manipulate glutamine metabolism for cancer immunotherapy. Immunotherapy Advances 1:1.
Crossref
Crossref
Wu-Xi Zhou, Chen Chen, Xiao-Qin Liu, Ying Li, Yao-Lan Lin, Xiu-Tao Wu, Ling-Yi Kong & Jian-Guang Luo. (2021) Discovery and optimization of withangulatin A derivatives as novel glutaminase 1 inhibitors for the treatment of triple-negative breast cancer. European Journal of Medicinal Chemistry 210, pages 112980.
Crossref
Crossref
Yang Zhou, Meilibanu Yusufu, Ting Zhang & Jing Wang. (2020) Silencing of miR-23a attenuates hydrogen peroxide (H2O2) induced oxidative damages in ARPE-19 cells by upregulating GLS1: an in vitro study. Cytotechnology 72:6, pages 873-884.
Crossref
Crossref
Zhefang Wang, Fanyu Liu, Ningbo Fan, Chenghui Zhou, Dai Li, Thomas Macvicar, Qiongzhu Dong, Christiane J. Bruns & Yue Zhao. (2020) Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies. Frontiers in Oncology 10.
Crossref
Crossref
Allison S. Cohen, Ling Geng, Ping Zhao, Allie Fu, Michael L. Schulte, Ramona Graves-Deal, M. Kay Washington, Jordan Berlin, Robert J. Coffey & H. Charles Manning. (2020) Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer. Translational Oncology 13:10, pages 100828.
Crossref
Crossref
Raj Shah & Suzie Chen. (2020) Metabolic Signaling Cascades Prompted by Glutaminolysis in Cancer. Cancers 12:9, pages 2624.
Crossref
Crossref
Pia Sommerkamp, Sandro Altamura, Simon Renders, Andreas Narr, Luisa Ladel, Petra Zeisberger, Paula Leonie Eiben, Malak Fawaz, Michael A. Rieger, Nina Cabezas-Wallscheid & Andreas Trumpp. (2020) Differential Alternative Polyadenylation Landscapes Mediate Hematopoietic Stem Cell Activation and Regulate Glutamine Metabolism. Cell Stem Cell 26:5, pages 722-738.e7.
Crossref
Crossref
Balazs Sarkadi, Katalin Meszaros, Ildiko Krencz, Letizia Canu, Lilla Krokker, Sara Zakarias, Gabor Barna, Anna Sebestyen, Judit Papay, Zoltan Hujber, Henriett Butz, Otto Darvasi, Peter Igaz, Judit Doczi, Michaela Luconi, Christos Chinopoulos & Attila Patocs. (2020) Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas. Cancers 12:3, pages 599.
Crossref
Crossref
Brendah K Masisi, Rokaya El Ansari, Lutfi Alfarsi, Emad A Rakha, Andrew R Green & Madeleine L Craze. (2020) The role of glutaminase in cancer. Histopathology 76:4, pages 498-508.
Crossref
Crossref
Shangui Liu, Ningqiu Li, Qiang Lin, Lihui Liu, Yinjie Niu, Hongru Liang, Zhibin Huang & Xiaozhe Fu. (2020) Glutaminase 1 in mandarin fish Siniperca chuatsi: Molecular characterization, expression pattern and function involving in virus replication. Aquaculture 519, pages 734924.
Crossref
Crossref
José M. Matés, Floriana J. Di Paola, José A. Campos-Sandoval, Sybille Mazurek & Javier Márquez. (2020) Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer. Seminars in Cell & Developmental Biology 98, pages 34-43.
Crossref
Crossref
Marilia M. Dias, Douglas Adamoski, Larissa M. dos Reis, Carolline F. R. Ascenção, Krishina R. S. de Oliveira, Ana Carolina Paschoalini Mafra, Alliny Cristiny da Silva Bastos, Melissa Quintero, Carolina de G. Cassago, Igor M. Ferreira, Carlos H. V. Fidelis, Silvana A. Rocco, Marcio Chaim Bajgelman, Zachary Stine, Ioana Berindan-Neagoe, George A. Calin, Andre Luis Berteli Ambrosio & Sandra Martha Gomes Dias. (2019) GLS2 is protumorigenic in breast cancers. Oncogene 39:3, pages 690-702.
Crossref
Crossref
Claudia Tanja MierkeClaudia Tanja Mierke. 2020. Cellular Mechanics and Biophysics. Cellular Mechanics and Biophysics
825
891
.
Yanming Li. 2020. Proceedings of the Future Technologies Conference (FTC) 2019. Proceedings of the Future Technologies Conference (FTC) 2019
676
687
.
Tineke W.H. Meijer, Monika G. Looijen‐Salamon, Jasper Lok, Michel van den Heuvel, Bastiaan Tops, Johannes H.A.M. Kaanders, Paul N. Span & Johan Bussink. (2019) Glucose and glutamine metabolism in relation to mutational status in NSCLC histological subtypes. Thoracic Cancer 10:12, pages 2289-2299.
Crossref
Crossref
Kai-Yin Yang, Can-Rong Wu, Meng-Zhu Zheng, Ruo-Tian Tang, Xing-Zhou Li, Li-Xia Chen & Hua Li. (2019) Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminase. Bioorganic Chemistry 92, pages 103186.
Crossref
Crossref
Lidija Milković, Marko Tomljanović, Ana Čipak Gašparović, Renata Novak Kujundžić, Dina Šimunić, Paško Konjevoda, Anamarija Mojzeš, Nikola Đaković, Neven Žarković & Koraljka Gall Trošelj. (2019) Nutritional Stress in Head and Neck Cancer Originating Cell Lines: The Sensitivity of the NRF2-NQO1 Axis. Cells 8:9, pages 1001.
Crossref
Crossref
M. Raymond V. Finlay, Mark Anderton, Andrew Bailey, Scott Boyd, Joanna Brookfield, Ceri Cairnduff, Mark Charles, Anne Cheasty, Susan E. Critchlow, Janet Culshaw, Tennyson Ekwuru, Ian Hollingsworth, Neil Jones, Fred Leroux, Mairi Littleson, Hollie McCarron, Jennifer McKelvie, Lorraine Mooney, J. Willem M. Nissink, David Perkins, Steve Powell, Mar Jimenez Quesada, Piotr Raubo, Verity Sabin, James Smith, Peter D. Smith, Andrew Stark, Attilla Ting, Peng Wang, Zena Wilson, Jon J. Winter-Holt, J. Matthew Wood, Gail L. Wrigley, Guoqing Yu & Peng Zhang. (2019) Discovery of a Thiadiazole–Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models. Journal of Medicinal Chemistry 62:14, pages 6540-6560.
Crossref
Crossref
Mark A. Gregory, Travis Nemkov, Hae J. Park, Vadym Zaberezhnyy, Sarah Gehrke, Biniam Adane, Craig T. Jordan, Kirk C. Hansen, Angelo D’Alessandro & James DeGregori. (2019) Targeting Glutamine Metabolism and Redox State for Leukemia Therapy. Clinical Cancer Research 25:13, pages 4079-4090.
Crossref
Crossref
Zhen Jiang, Chenghua Zhang, Li Gan, Yuewang Jia, Yu Xiong, Yujiang Chen, Zhi Wang, Linfeng Wang, Hao Luo, Juexi Li, Rui Zhu, Xingli Ji, Qin Yu & Li Wang. (2019) iTRAQ‐Based Quantitative Proteomics Approach Identifies Novel Diagnostic Biomarkers That Were Essential for Glutamine Metabolism and Redox Homeostasis for Gastric Cancer. PROTEOMICS – Clinical Applications 13:4.
Crossref
Crossref
Zhu-Jun Cheng, Du-Ling Miao, Qiu-Yun Su, Xiao-Li Tang, Xiao-Lei Wang, Li-Bin Deng, Hui-Dong Shi & Hong-Bo Xin. (2018) THZ1 suppresses human non-small-cell lung cancer cells in vitro through interference with cancer metabolism. Acta Pharmacologica Sinica 40:6, pages 814-822.
Crossref
Crossref
Elyssa Bernfeld & David A. Foster. (2019) Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells. Trends in Endocrinology & Metabolism 30:6, pages 357-368.
Crossref
Crossref
Ruifang Teng, Zongyuan Liu, Haiping Tang, Wenhao Zhang, Yuling Chen, Renhua Xu, Liang Chen, Jiangping Song, Xiaohui Liu & Haiteng Deng. (2019) HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells. Redox Biology 24, pages 101218.
Crossref
Crossref
Ileana Hernández‐Reséndiz, Juan Carlos Gallardo‐Pérez, Ambar López‐Macay, Diana Xochiquetzal Robledo‐Cadena, Enrique García‐Villa, Patricio Gariglio, Emma Saavedra, Rafael Moreno‐Sánchez & Sara Rodríguez‐Enríquez. (2018)
Mutant p53
R248Q
downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells
. Journal of Cellular Physiology 234:5, pages 5524-5536.
Crossref
Crossref
Lichchavi Rajasinghe, Melanie Hutchings & Smiti Gupta. (2019) Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach. Metabolites 9:3, pages 50.
Crossref
Crossref
Subbroto Saha, S.M. Islam, M. Abdullah-AL-Wadud, Saiful Islam, Farman Ali & Kyoung Park. (2019) Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer. Journal of Clinical Medicine 8:3, pages 355.
Crossref
Crossref
Laure-Anne Teuwen, Vincent Geldhof & Peter Carmeliet. (2019) How glucose, glutamine and fatty acid metabolism shape blood and lymph vessel development. Developmental Biology 447:1, pages 90-102.
Crossref
Crossref
Chiara Damiani, Davide Maspero, Marzia Di Filippo, Riccardo Colombo, Dario Pescini, Alex Graudenzi, Hans Victor Westerhoff, Lilia Alberghina, Marco Vanoni & Giancarlo Mauri. (2019) Integration of single-cell RNA-seq data into population models to characterize cancer metabolism. PLOS Computational Biology 15:2, pages e1006733.
Crossref
Crossref
Xi Xu, Ying Meng, Lei Li, Pengfei Xu, Jubo Wang, Zhiyu Li & Jinlei Bian. (2018) Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions. Journal of Medicinal Chemistry 62:3, pages 1096-1115.
Crossref
Crossref
Christian R. Hoerner, Viola J. Chen & Alice C. Fan. (2019) The ‘Achilles Heel’ of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy. Kidney Cancer 3:1, pages 15-29.
Crossref
Crossref
Karolien Vanhove, Elien Derveaux, Geert-Jan Graulus, Liesbet Mesotten, Michiel Thomeer, Jean-Paul Noben, Wanda Guedens & Peter Adriaensens. (2019) Glutamine Addiction and Therapeutic Strategies in Lung Cancer. International Journal of Molecular Sciences 20:2, pages 252.
Crossref
Crossref
Sarah C. Zimmermann, Bridget Duvall & Takashi Tsukamoto. (2018) Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase. Journal of Medicinal Chemistry 62:1, pages 46-59.
Crossref
Crossref
Judith E. Unterlass & Nicola J. Curtin. (2019) Warburg and Krebs and related effects in cancer. Expert Reviews in Molecular Medicine 21.
Crossref
Crossref
Binghua Li, Yajuan Cao, Gang Meng, Liyuan Qian, Tiancheng Xu, Chen Yan, Ouyang Luo, Shaohe Wang, Jiwu Wei, Yitao Ding & Decai Yu. (2019) Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway. EBioMedicine 39, pages 239-254.
Crossref
Crossref
Tineke W.H. Meijer, Wenny J.M. Peeters, Ludwig J. Dubois, Marike W. van Gisbergen, Rianne Biemans, Jan-Hendrik Venhuizen, Paul N. Span & Johan Bussink. (2018) Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancer. Lung Cancer 126, pages 32-40.
Crossref
Crossref
Cuifeng Wang, Jiamin Wu, Zhongjuan Wang, Zeping Yang, Zhi Li, Huihui Deng, Long Li, Xiao Peng & Min Feng. (2018) Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5. Biomaterials 183, pages 77-92.
Crossref
Crossref
Carolline Fernanda Rodrigues Ascenção, Raghavendra Sashi Krishna Nagampalli, Zeyaul Islam, Matheus Pinto Pinheiro, Larissa Menezes dos Reis, Bianca Alves Pauletti, Carolina Aparecida de Guzzi Cassago, Daniela Campos Granato, Adriana Franco Paes Leme & Sandra Martha Gomes Dias. (2018) N-terminal phosphorylation of glutaminase C decreases its enzymatic activity and cancer cell migration. Biochimie 154, pages 69-76.
Crossref
Crossref
Ettaib El Marabti & Ihab Younis. (2018) The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer. Frontiers in Molecular Biosciences 5.
Crossref
Crossref
Anneleen Daemen, Bonnie Liu, Kyung Song, Mandy Kwong, Min Gao, Rebecca Hong, Michelle Nannini, David Peterson, Bianca M. Liederer, Cecile de la Cruz, Dewakar Sangaraju, Allan Jaochico, Xiaofeng Zhao, Wendy Sandoval, Thomas Hunsaker, Ron Firestein, Sheerin Latham, Deepak Sampath, Marie Evangelista & Georgia Hatzivassiliou. (2018) Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State. Cell Metabolism 28:3, pages 383-399.e9.
Crossref
Crossref
Liang Wang, Wen Peng, Tianming Wu, Pengchi Deng & Ying-Lan Zhao. (2018) Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment. Cell Death Discovery 4:1.
Crossref
Crossref
Fei Liu, Xiaoxia Xu, Hua Zhu, Yan Zhang, Jianhua Yang, Lifang Zhang, Nan Li, Lin Zhu, Hank F. Kung & Zhi Yang. (2018)
PET Imaging of
18
F-(2
S
,4
R
)4-Fluoroglutamine Accumulation in Breast Cancer: From Xenografts to Patients
. Molecular Pharmaceutics 15:8, pages 3448-3455.
Crossref
Crossref
Irfana Soomro, Ying Sun, Zhai Li, Lonnette Diggs, Georgia Hatzivassiliou, Ajit G Thomas, Rana Rais, Barbara S Slusher, Stefan Somlo & Edward Y Skolnik. (2018) Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease. Nephrology Dialysis Transplantation 33:8, pages 1343-1353.
Crossref
Crossref
Chioniso P. Masamha & Patrick LaFontaine. (2018) Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy. Journal of Cellular Biochemistry 119:7, pages 6136-6145.
Crossref
Crossref
Tianyu Han, Weihua Zhan, Mingxi Gan, Fanrong Liu, Bentong Yu, Y. Eugene Chin & Jian-Bin Wang. (2018) Phosphorylation of glutaminase by PKCε is essential for its enzymatic activity and critically contributes to tumorigenesis. Cell Research 28:6, pages 655-669.
Crossref
Crossref
Sanaya Bamji-Stocke, Victor van Berkel, Donald M. Miller & Hermann B. Frieboes. (2018) A review of metabolism-associated biomarkers in lung cancer diagnosis and treatment. Metabolomics 14:6.
Crossref
Crossref
Qingqiu Huang, Clint Stalnecker, Chengliang Zhang, Lee A. McDermott, Prema Iyer, Jason O’Neill, Shawn Reimer, Richard A. Cerione & William P. Katt. (2018) Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism. Journal of Biological Chemistry 293:10, pages 3535-3545.
Crossref
Crossref
Katerina Rohlenova, Koen Veys, Ines Miranda-Santos, Katrien De Bock & Peter Carmeliet. (2018) Endothelial Cell Metabolism in Health and Disease. Trends in Cell Biology 28:3, pages 224-236.
Crossref
Crossref
Tanya Schild, Vivien Low, John Blenis & Ana P. Gomes. (2018) Unique Metabolic Adaptations Dictate Distal Organ-Specific Metastatic Colonization. Cancer Cell 33:3, pages 347-354.
Crossref
Crossref
Marina Wright Muelas, Fernando Ortega, Rainer Breitling, Claus Bendtsen & Hans V. Westerhoff. (2018) Rational cell culture optimization enhances experimental reproducibility in cancer cells. Scientific Reports 8:1.
Crossref
Crossref
Yuan Tian, Wei Du, Sha Cao, Yue Wu, Ning Dong, Yan Wang & Ying Xu. (2017) Systematic analyses of glutamine and glutamate metabolisms across different cancer types. Chinese Journal of Cancer 36:1.
Crossref
Crossref
Yuju Li, Justin Peer, Runze Zhao, Yinghua Xu, Beiqing Wu, Yi Wang, Changhai Tian, Yunlong Huang & Jialin Zheng. (2017) Serial deletion reveals structural basis and stability for the core enzyme activity of human glutaminase 1 isoforms: relevance to excitotoxic neurodegeneration. Translational Neurodegeneration 6:1.
Crossref
Crossref
Cecilia Roux, Chiara Riganti, Sammy Ferri Borgogno, Roberta Curto, Claudia Curcio, Valeria Catanzaro, Giuseppe Digilio, Sergio Padovan, Maria Paola Puccinelli, Monica Isabello, Silvio Aime, Paola Cappello & Francesco Novelli. (2017) Endogenous glutamine decrease is associated with pancreatic cancer progression. Oncotarget 8:56, pages 95361-95376.
Crossref
Crossref
Luyuan Li, Josiane E. Eid, Ana C. Paz & Jonathan C. Trent. (2017) Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy. BioDrugs 31:5, pages 379-392.
Crossref
Crossref
Michael Lampa, Heike Arlt, Timothy He, Beatriz Ospina, Jason Reeves, Bailin Zhang, Joshua Murtie, Gejing Deng, Claude Barberis, Dietmar Hoffmann, Hong Cheng, Jack Pollard, Christopher Winter, Victoria Richon, Carlos Garcia-Escheverria, Francisco Adrian, Dmitri Wiederschain & Lakshmi Srinivasan. (2017) Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition. PLOS ONE 12:9, pages e0185092.
Crossref
Crossref
Alexander Muir, Laura V Danai, Dan Y Gui, Chiara Y Waingarten, Caroline A Lewis & Matthew G Vander Heiden. (2017) Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition. eLife 6.
Crossref
Crossref
Hongling Huang, Saar Vandekeere, Joanna Kalucka, Laura Bierhansl, Annalisa Zecchin, Ulrike Brüning, Asjad Visnagri, Nadira Yuldasheva, Jermaine Goveia, Bert Cruys, Katleen Brepoels, Sabine Wyns, Stephen Rayport, Bart Ghesquière, Stefan Vinckier, Luc Schoonjans, Richard Cubbon, Mieke Dewerchin, Guy Eelen & Peter Carmeliet. (2017) Role of glutamine and interlinked asparagine metabolism in vessel formation. The EMBO Journal 36:16, pages 2334-2352.
Crossref
Crossref
N.D. Amoedo, E. Obre & R. Rossignol. (2017) Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1858:8, pages 674-685.
Crossref
Crossref
Wei-Qun Lu, Ying-Ying Hu, Xiao-Ping Lin & Wei Fan. (2017) Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells. Oncotarget 8:27, pages 44171-44185.
Crossref
Crossref
Chi V Dang. (2017)
c‐
MYC mRNA
tail tale about glutamine control of transcription
. The EMBO Journal 36:13, pages 1806-1808.
Crossref
Crossref
Ravyn M. Thompson, Dominik Dytfeld, Leticia Reyes, Reeder M. Robinson, Brittany Smith, Yefim Manevich, Andrzej Jakubowiak, Mieczyslaw Komarnicki, Anna Przybylowicz-Chalecka, Tomasz Szczepaniak, Amit K. Mitra, Brian G. Van Ness, Magdalena Luczak & Nathan G. Dolloff. (2017) Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells. Oncotarget 8:22, pages 35863-35876.
Crossref
Crossref
Emma R Still & Mariia O Yuneva. (2017) Hopefully devoted to Q: targeting glutamine addiction in cancer. British Journal of Cancer 116:11, pages 1375-1381.
Crossref
Crossref
Tianyu Han, Meng Guo, Tingting Zhang, Mingxi Gan, Caifeng Xie & Jian-Bin Wang. (2016) A novel glutaminase inhibitor-968 inhibits the migration and proliferation of non-small cell lung cancer cells by targeting EGFR/ERK signaling pathway. Oncotarget 8:17, pages 28063-28073.
Crossref
Crossref
Clint A. Stalnecker, Jon W. Erickson & Richard A. Cerione. (2017) Conformational changes in the activation loop of mitochondrial glutaminase C: A direct fluorescence readout that distinguishes the binding of allosteric inhibitors from activators. Journal of Biological Chemistry 292:15, pages 6095-6107.
Crossref
Crossref
Joo Young Kim, Sun-Hee Heo, Seul Ki Choi, In Hye Song, In Ah Park, Young-Ae Kim, Hye Seon Park, Suk Young Park, Won Seon Bang, Gyungyub Gong & Hee Jin Lee. (2017) Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes. Virchows Archiv 470:4, pages 381-389.
Crossref
Crossref
William P Katt, Michael J Lukey & Richard A Cerione. (2017) A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis. Future Medicinal Chemistry 9:2, pages 223-243.
Crossref
Crossref
B I Ratnikov, D A Scott, A L Osterman, J W Smith & Z A Ronai. (2016) Metabolic rewiring in melanoma. Oncogene 36:2, pages 147-157.
Crossref
Crossref
Naniye Mallı Cetinbas, Jessica Sudderth, Robert C. Harris, Aysun Cebeci, Gian L. Negri, Ömer H. Yılmaz, Ralph J. DeBerardinis & Poul H. Sorensen. (2016) Glucose-dependent anaplerosis in cancer cells is required for cellular redox balance in the absence of glutamine. Scientific Reports 6:1.
Crossref
Crossref
Jae-Seon Lee, Joon H Kang, Seon-Hyeong Lee, Dongwan Hong, Jaekyoung Son, Kyeong M Hong, Jaewhan Song & Soo-Youl Kim. (2016) Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC. Cell Death & Disease 7:12, pages e2511-e2511.
Crossref
Crossref
Md Maksudul Alam, Sneha Lal, Keely E. FitzGerald & Li Zhang. (2016) A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors. Clinical and Translational Medicine 5:1.
Crossref
Crossref
Brian J. Altman, Zachary E. Stine & Chi V. Dang. (2016) From Krebs to clinic: glutamine metabolism to cancer therapy. Nature Reviews Cancer 16:10, pages 619-634.
Crossref
Crossref
Xuanzhu Zhou, Wei Zheng, G.A. Nagana Gowda, Daniel Raftery, Shawn S. Donkin, Brian Bequette & Dorothy Teegarden. (2016) 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell. The Journal of Steroid Biochemistry and Molecular Biology 163, pages 147-156.
Crossref
Crossref
Weng Howe Chan, Mohd Saberi Mohamad, Safaai Deris, Nazar Zaki, Shahreen Kasim, Sigeru Omatu, Juan Manuel Corchado & Hany Al Ashwal. (2016) Identification of informative genes and pathways using an improved penalized support vector machine with a weighting scheme. Computers in Biology and Medicine 77, pages 102-115.
Crossref
Crossref
Sarath Ramachandran, Catherine Qiurong Pan, Sarah C. Zimmermann, Bridget Duvall, Takashi Tsukamoto, Boon Chuan Low & J. Sivaraman. (2016) Structural basis for exploring the allosteric inhibition of human kidney type glutaminase. Oncotarget 7:36, pages 57943-57954.
Crossref
Crossref
Yunxing Li, Jon W. Erickson, Clint A. Stalnecker, William P. Katt, Qingqiu Huang, Richard A. Cerione & Sekar Ramachandran. (2016) Mechanistic Basis of Glutaminase Activation. Journal of Biological Chemistry 291:40, pages 20900-20910.
Crossref
Crossref
Thomas Bertero, William M. Oldham, Katherine A. Cottrill, Sabrina Pisano, Rebecca R. Vanderpool, Qiujun Yu, Jingsi Zhao, Yiyin Tai, Ying Tang, Ying-Yi Zhang, Sofiya Rehman, Masataka Sugahara, Zhi Qi, John GorcsanIIIIII, Sara O. Vargas, Rajan Saggar, Rajeev Saggar, W. Dean Wallace, David J. Ross, Kathleen J. Haley, Aaron B. Waxman, Victoria N. Parikh, Teresa De Marco, Priscilla Y. Hsue, Alison Morris, Marc A. Simon, Karen A. Norris, Cedric Gaggioli, Joseph Loscalzo, Joshua Fessel & Stephen Y. Chan. (2016) Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. Journal of Clinical Investigation 126:9, pages 3313-3335.
Crossref
Crossref
Belén Callejón-Leblic, Tamara García-Barrera, Jesús Grávalos-Guzmán, Antonio Pereira-Vega & José Luis Gómez-Ariza. (2016) Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform. Journal of Proteomics 145, pages 197-206.
Crossref
Crossref
Lili Guo, Bo Zhou, Zhengqing Liu, Ying Xu, Hao Lu, Meng Xia, Ensong Guo, Wanying Shan, Gang Chen & Changyu Wang. (2016) Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling. Tumor Biology 37:8, pages 11007-11015.
Crossref
Crossref
Zeynep Sener, Fritjof H. Cederkvist, Roman Volchenkov, Halvor L. Holen & Bjørn S. Skålhegg. (2016) T Helper Cell Activation and Expansion Is Sensitive to Glutaminase Inhibition under Both Hypoxic and Normoxic Conditions. PLOS ONE 11:7, pages e0160291.
Crossref
Crossref
A Sveen, S Kilpinen, A Ruusulehto, R A Lothe & R I Skotheim. (2015) Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes. Oncogene 35:19, pages 2413-2427.
Crossref
Crossref
Sarah C. Zimmermann, Emily F. Wolf, Andrew Luu, Ajit G. Thomas, Marigo Stathis, Brad Poore, Christopher Nguyen, Anne Le, Camilo Rojas, Barbara S. Slusher & Takashi Tsukamoto. (2016) Allosteric Glutaminase Inhibitors Based on a 1,4-Di(5-amino-1,3,4-thiadiazol-2-yl)butane Scaffold. ACS Medicinal Chemistry Letters 7:5, pages 520-524.
Crossref
Crossref
Victoria M. Youngblood, Laura C. Kim, Deanna N. Edwards, Yoonha Hwang, Pranav R. Santapuram, Steven M. Stirdivant, Pengcheng Lu, Fei Ye, Dana M. Brantley-Sieders & Jin Chen. (2016) The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer. Cancer Research 76:7, pages 1825-1836.
Crossref
Crossref
Daniel R. Sappington, Eric R. Siegel, Gloria Hiatt, Abhishek Desai, Rosalind B. Penney, Azemat Jamshidi-Parsian, Robert J. Griffin & Gunnar Boysen. (2016) Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:4, pages 836-843.
Crossref
Crossref
Shawn M. Davidson, Thales Papagiannakopoulos, Benjamin A. Olenchock, Julia E. Heyman, Mark A. Keibler, Alba Luengo, Matthew R. Bauer, Abhishek K. Jha, James P. O’Brien, Kerry A. Pierce, Dan Y. Gui, Lucas B. Sullivan, Thomas M. Wasylenko, Lakshmipriya Subbaraj, Christopher R. Chin, Gregory Stephanopolous, Bryan T. Mott, Tyler Jacks, Clary B. Clish & Matthew G. Vander Heiden. (2016) Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer. Cell Metabolism 23:3, pages 517-528.
Crossref
Crossref
Rance Nault, Kelly A. Fader, Mathew P. Kirby, Shaimaa Ahmed, Jason Matthews, A. Daniel Jones, Sophia Y. Lunt & Timothy R. Zacharewski. (2016)
Pyruvate Kinase Isoform Switching and Hepatic Metabolic Reprogramming by the Environmental Contaminant 2,3,7,8-Tetrachlorodibenzo-
p
-Dioxin
. Toxicological Sciences 149:2, pages 358-371.
Crossref
Crossref
Monika Szeliga, Jarosław Ćwikła, Marta Obara-Michlewska, Andrzej Cichocki & Jan Albrecht. (2016) Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoform. Experimental and Molecular Pathology 100:1, pages 74-78.
Crossref
Crossref
Roxana S. Redis, Luz E. Vela, Weiqin Lu, Juliana Ferreira de Oliveira, Cristina Ivan, Cristian Rodriguez-Aguayo, Douglas Adamoski, Barbara Pasculli, Ayumu Taguchi, Yunyun Chen, Agustin F. Fernandez, Luis Valledor, Katrien Van Roosbroeck, Samuel Chang, Maitri Shah, Garrett Kinnebrew, Leng Han, Yaser Atlasi, Lawrence H. Cheung, Gilbert Y. Huang, Paloma Monroig, Marc S. Ramirez, Tina Catela Ivkovic, Long Van, Hui Ling, Roberta Gafà, Sanja Kapitanovic, Giovanni Lanza, James A. Bankson, Peng Huang, Stephen Y. Lai, Robert C. Bast, Michael G. Rosenblum, Milan Radovich, Mircea Ivan, Geoffrey Bartholomeusz, Han Liang, Mario F. Fraga, William R. Widger, Samir Hanash, Ioana Berindan-Neagoe, Gabriel Lopez-Berestein, Andre L.B. Ambrosio, Sandra M. Gomes Dias & George A. Calin. (2016) Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Molecular Cell 61:4, pages 520-534.
Crossref
Crossref
Caifeng Xie, Jiangbo Jin, Xujie Bao, Wei-Hua Zhan, Tian-Yu Han, Mingxi Gan, Chengfu Zhang & Jianbin Wang. (2015) Inhibition of mitochondrial glutaminase activity reverses acquired erlotinib resistance in non-small cell lung cancer. Oncotarget 7:1, pages 610-621.
Crossref
Crossref
Tzu-Fang Lou, Deepa Sethuraman, Patrick Dospoy, Pallevi Srivastva, Hyun Seok Kim, Joongsoo Kim, Xiaotu Ma, Pei-Hsuan Chen, Kenneth E. Huffman, Robin E. Frink, Jill E. Larsen, Cheryl Lewis, Sang-Won Um, Duk-Hwan Kim, Jung-Mo Ahn, Ralph J. DeBerardinis, Michael A. White, John D. Minna & Hyuntae Yoo. (2016) Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker. Cancer Prevention Research 9:1, pages 43-52.
Crossref
Crossref
Nathan L. Ta & Thomas N. Seyfried. (2015) Influence of Serum and Hypoxia on Incorporation of [14C]-d-Glucose or [14C]-l-Glutamine into Lipids and Lactate in Murine Glioblastoma Cells. Lipids 50:12, pages 1167-1184.
Crossref
Crossref
Koichi Sugimoto, Hiroshi I. Suzuki, Tsutomu Fujimura, Asami Ono, Naoko Kaga, Yasushi Isobe, Makoto Sasaki, Hikari Taka, Kohei Miyazono & Norio Komatsu. (2015) A clinically attainable dose of L‐asparaginase targets glutamine addiction in lymphoid cell lines. Cancer Science 106:11, pages 1534-1543.
Crossref
Crossref
Huichun Zhan, Kristen Ciano, Katherine Dong & Stanley Zucker. (2015) Targeting glutamine metabolism in myeloproliferative neoplasms. Blood Cells, Molecules, and Diseases 55:3, pages 241-247.
Crossref
Crossref
Moloy T. Goswami, Guoan Chen, Balabhadrapatruni V.S.K. Chakravarthi, Satya S. Pathi, Sharath K. Anand, Shannon L. Carskadon, Thomas J. Giordano, Arul M. Chinnaiyan, Dafydd G. Thomas, Nallasivam Palanisamy, David G. Beer & Sooryanarayana Varambally. (2015)
Role and regulation of coordinately expressed
de novo
purine biosynthetic enzymes
PPAT
and
PAICS
in lung cancer
. Oncotarget 6:27, pages 23445-23461.
Crossref
Crossref
Nathalie JacqueAnne Marie RonchettiClément LarrueGodelieve MeunierRudy BirsenLise WillemsEstelle SalandJustine Decroocq, Thiago Trovati Maciel, Mireille LambertLaury PoulainMarie Anne HospitalPierre SujobertLaure JosephNicolas ChapuisCatherine LacombeIvan Cruz Moura, Susan Demo, Jean Emmanuel SarryChristian RecherPatrick MayeuxJérôme TamburiniDidier Bouscary. (2015) Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood 126:11, pages 1346-1356.
Crossref
Crossref
Yan Xiang, Zachary E. Stine, Jinsong Xia, Yunqi Lu, Roddy S. O’Connor, Brian J. Altman, Annie L. Hsieh, Arvin M. Gouw, Ajit G. Thomas, Ping Gao, Linchong Sun, Libing Song, Benedict Yan, Barbara S. Slusher, Jingli Zhuo, London L. Ooi, Caroline G.L. Lee, Anthony Mancuso, Andrew S. McCallion, Anne Le, Michael C. Milone, Stephen Rayport, Dean W. Felsher & Chi V. Dang. (2015) Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. Journal of Clinical Investigation 125:6, pages 2293-2306.
Crossref
Crossref
Ja Seung Koo & Jin Sook Yoon. (2015) Expression of Metabolism-Related Proteins in Lacrimal Gland Adenoid Cystic Carcinoma. American Journal of Clinical Pathology 143:4, pages 584-592.
Crossref
Crossref
Hyuknam Kwon, Sehyun Oh, Xing Jin, Yong Jin An & Sunghyouk Park. (2015) Cancer metabolomics in basic science perspective. Archives of Pharmacal Research 38:3, pages 372-380.
Crossref
Crossref
Edward Sanders & Svenja Diehl. (2015) Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma. Oncoscience 2:2, pages 151-186.
Crossref
Crossref
Clint A. Stalnecker, Scott M. UlrichYunxing Li, Sekar Ramachandran, Mary Kate McBrayer, Ralph J. DeBerardinis, Richard A. CerioneJon W. Erickson. (2014) Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells. Proceedings of the National Academy of Sciences 112:2, pages 394-399.
Crossref
Crossref
Javier Márquez, José M. Matés, Francisco J. Alonso, Mercedes Martín-Rufián, Carolina Lobo & José A. Campos-Sandoval. 2015. Tumor Cell Metabolism. Tumor Cell Metabolism
257
286
.
Danielle B. Ulanet, Kiley Couto, Abhishek Jha, Sung Choe, Amanda Wang, Hin-Koon Woo, Mya Steadman, Byron DeLaBarre, Stefan Gross, Edward Driggers, Marion Dorsch & Jonathan B. Hurov. (2014) Mesenchymal Phenotype Predisposes Lung Cancer Cells to Impaired Proliferation and Redox Stress in Response to Glutaminase Inhibition. PLoS ONE 9:12, pages e115144.
Crossref
Crossref
Zheng Xia, Lawrence A. Donehower, Thomas A. Cooper, Joel R. Neilson, David A. Wheeler, Eric J. Wagner & Wei Li. (2014) Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types. Nature Communications 5:1.
Crossref
Crossref
Björn Kruspig, Boris Zhivotovsky & Vladimir Gogvadze. (2014) Mitochondrial substrates in cancer: Drivers or passengers?. Mitochondrion 19, pages 8-19.
Crossref
Crossref
Matt I. Gross, Susan D. Demo, Jennifer B. Dennison, Lijing Chen, Tania Chernov-Rogan, Bindu Goyal, Julie R. Janes, Guy J. Laidig, Evan R. Lewis, Jim Li, Andrew L. MacKinnon, Francesco Parlati, Mirna L.M. Rodriguez, Peter J. Shwonek, Eric B. Sjogren, Timothy F. Stanton, Taotao Wang, Jinfu Yang, Frances Zhao & Mark K. Bennett. (2014) Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics 13:4, pages 890-901.
Crossref
Crossref
William P. Katt & Richard A. Cerione. (2014) Glutaminase regulation in cancer cells: a druggable chain of events. Drug Discovery Today 19:4, pages 450-457.
Crossref
Crossref
Amr Mohamed, Xingming Deng, Fadlo R. Khuri & Taofeek K. Owonikoko. (2014) Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer. Clinical Lung Cancer 15:1, pages 7-15.
Crossref
Crossref
Luika A. Timmerman, Thomas Holton, Mariia Yuneva, Raymond J. Louie, Mercè Padró, Anneleen Daemen, Min Hu, Denise A. Chan, Stephen P. Ethier, Laura J. van ‘t Veer, Kornelia Polyak, Frank McCormick & Joe W. Gray. (2013) Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target. Cancer Cell 24:4, pages 450-465.
Crossref
Crossref
Christopher T. Hensley, Ajla T. Wasti & Ralph J. DeBerardinis. (2013) Glutamine and cancer: cell biology, physiology, and clinical opportunities. Journal of Clinical Investigation 123:9, pages 3678-3684.
Crossref
Crossref
Weijiao Huang, Wooyoung Choi, Yuling Chen, Qi Zhang, Haiteng Deng, Wei He & Yigong Shi. (2013) A proposed role for glutamine in cancer cell growth through acid resistance. Cell Research 23:5, pages 724-727.
Crossref
Crossref